Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Erratum (v130,p308)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mendes, E. S.
Right arrow Articles by Wanner, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mendes, E. S.
Right arrow Articles by Wanner, A.
(Chest. 2006;129:893-898.)
© 2006 American College of Chest Physicians

Airway Blood Flow Reactivity in Healthy Smokers and in Ex-Smokers With or Without COPD*

Eliana S. Mendes, MD; Michael A. Campos, MD and Adam Wanner, MD

* From the Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Miami School of Medicine, Miami, FL.

Correspondence to: Eliana Mendes, MD, Division of Pulmonary and Critical Care Medicine, University of Miami School of Medicine, 1600 NW 10th Ave, 7064-A, Miami, FL 33136; e-mail: emendes{at}med.miami.edu

Abstract

Study objectives: Cigarette smoking has been associated with impaired endothelium-dependent relaxation responses in the brachial and coronary arteries (endothelial dysfunction). The aim of the present study was to determine whether the airway circulation is also affected and whether pharmacologic treatment has an effect on endothelial function in patients with COPD.

Methods and patients: Airway blood flow (Qaw) responses to therapy with inhaled albuterol, which causes endothelium-dependent vasodilation, were measured with a noninvasive soluble-gas-uptake technique in age-matched healthy current smokers (n = 10), healthy ex-smokers (n = 10), ex-smokers with COPD (n = 10), and healthy lifetime nonsmokers. In the ex-smokers with COPD, the albuterol responsiveness measurement was repeated after 4 weeks of treatment with fluticasone/salmeterol and after a drug washout period of 4 or 8 weeks.

Results: The mean (± SE) baseline Qaw values ranged between 40.7 ± 3.9 and 50.9 ± 2.8 µL/min/mL anatomic dead space in the four groups (differences were not significant). The mean FEV1 was 53.4 ± 2.3% predicted in the ex-smokers with COPD. Albuterol inhalation increased mean Qaw significantly in lifetime nonsmokers (50.1 ± 8.3% predicted; p < 0.05) and healthy ex-smokers (37.2 ± 3.4% predicted; p < 0.05), but not in healthy current smokers (13.9 ± 3.2% predicted; difference was not significant) and ex-smokers with COPD (9.7 ± 4.5% predicted; difference was not significant). While fluticasone/salmeterol did not change Qaw significantly, it restored albuterol responsiveness (67.6 ± 11.1% predicted; p < 0.05) in the ex-smokers with COPD; this effect was no longer seen after the drug washout period.

Conclusions: Cigarette smoking is associated with a blunted vasodilator response to inhaled albuterol in the airway as an expression of endothelial dysfunction, with a partial recovery of albuterol responsiveness after smoking cessation in healthy ex-smokers but not in ex-smokers with COPD. In the latter group, combined glucocorticoid/long-acting ß2-adrenergic agonist treatment restores albuterol responsiveness. The role of endothelial dysfunction in the physiopathology of COPD remains to be examined.

Key Words: ß2-adrenergic agonists • bronchial circulation • COPD • endothelial function • glucocorticoids • smoking




This article has been cited by other articles:


Home page
ChestHome page
J.-P. Zheng, L. Yang, Y. M. Wu, P. Chen, Z. G. Wen, W.-J. Huang, Y. Shi, C.-Z. Wang, S.-G. Huang, T.-y. Sun, et al.
The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD
Chest, December 1, 2007; 132(6): 1756 - 1763.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American College of Chest Physicians.